Nitric oxide releasing prodrugs of diaryl2-(5H)-furanones as cyclooxygenase-2 inhibitors

Details for Australian Patent Application No. 2004240700 (hide)

International Classifications

Event Publications

25 August 2005 PCT application entered the National Phase

PCT publication WO2004/103955 Priority application(s): WO2004/103955

16 March 2006 Assignment before Grant

Merck Frosst Canada & Co The application has been assigned to Merck Frosst Company Assignments before Grant, Section 113

11 February 2010 Application Accepted

Published as AU-B-2004240700

1 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.